ABSTRACT
The understanding of biological pathways related to loneliness and social isolation remains incomplete. Cutting-edge population-based proteomics offers opportunities to uncover novel biological pathways linked to social deficits. This study employed a proteome-wide and data-driven approach to estimate the cross-sectional associations between objective measures of social connections (i.e., social isolation) and subjective measures (i.e., loneliness) with protein abundance, using the English Longitudinal Study of Ageing. Greater social isolation was associated with higher levels of 11 proteins (TNFRSF10A, MMP12, TRAIL-R2, SKR3, TNFRSF11A, VSIG2, PRSS8, FGFR2, KIM1, REN, and NEFL) after minimal adjustments; and three proteins were significantly associated after full adjustments (TNFRSF10A, TNFRSF11A, and HAOX1). Findings from two-sample Mendelian randomization indicated that a lower frequency of in-person social contact with friends or family causally increased levels of TNFRSF10A, TRAIL-R2, TNFRSF11A, and KIM1, and decreased the level of NEFL. The study also highlighted several enriched biological pathways, including necrosis and cell death regulation, dimerization of procaspase-8, and inhibition of caspase-8 pathways, which have previously not been linked to social deficits. These findings could help explain the relationship between social deficits and disease, confirming the importance of continuing to explore novel biological pathways associated with social deficits.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The English Longitudinal Study of Ageing is funded by the National Institute on Aging (grant number R01AG17644) and the National Institute for Health and Care Research (198/1074-02). The National Institute of Aging (NIA) (grant No. [R01AG17644]) funded the proteomics data curation in ELSA. J.G. is supported by the NIA (grant No. [R01AG17644]). Z.P. is supported by the Economic and Social Research Council (ESRC) and the Biotechnology and Biological Sciences Research Council (BBSRC) UCL Soc-B Doctoral Studentship programme (ES/P000347/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical consent has been obtained for all waves and components of ELSA, according to the ethical approval system in operation at the time and in accordance with the Declaration of Helsinki. UK Biobank has approval from the Northwest Multi-center Research Ethics Committee (MREC) as a Research Tissue Bank (RTB) approval.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
DATA AVAILABILITY
The ELSA data is available on the UK Data Service. The proteomics data in ELSA will be deposited on the UK Data Service upon publication.
All GWAS summary statistics are available online at:
